FILTER

Refine your search with the following facets to narrow down your results.

10 Current news of Nuevolution

Nuevolution announces license agreement with Merck

25-Feb-2014 - Nuevolution A/S announced that it has entered an exclusive license agreement with a subsidiary of Merck & Co., Inc., known as MSD outside the United States and Canada, for small molecule compounds targeting an undisclosed intracellular target for use as leads in Merck’s drug discovery and ...

milestone payments

Nuevolution Announces Collaboration in Drug Discovery with Boehringer Ingelheim

22-Sep-2011 - Nuevolution A/S announced that it has entered into collaboration with Boehringer Ingelheim, using Nuevolution’s proprietary Chemetics® drug discovery technology. Within the framework of the collaboration, hundreds of millions of diverse small molecules will be screened to discover and advance ...

drug discovery collaborations drug screening

Nuevolution announces receipt of milestone payment from Merck & Co., Inc.

03-Nov-2009 - Nuevolution A/S announced that it has received a milestone payment derived from its collaboration with Merck & Co. Inc. The payment was triggered following identification of several candidate molecules that conformed to the prespecified criteria established under the terms of the original ...

milestone payments protein interactions

Nuevolution Announces New Research Collaboration with Novartis

01-Sep-2009 - Nuevolution A/S announced that it has entered into a drug discovery collaboration with Novartis. During the collaboration, Nuevolution will apply its proprietary Chemetics® drug discovery technology to identify novel small molecule leads against drug targets of interest to Novartis. The ...

drug discovery drug discovery collaborations drug screening +2

Nuevolution Announces Worldwide Technology Cross-Licensing Agreement with GSK

29-Jul-2009 - Nuevolution announced the execution of a worldwide technology cross-licensing agreement with GlaxoSmithKline. The agreement relates to a number of patented technologies for rapid synthesis and DNA-tagging of hundreds of millions of chemically diverse drug-like small molecule compounds and the ...

patents synthesis

Nuevolution Announces Research and Development Collaboration with Merck & Co. Inc.

20-Jun-2008 - Nuevolution A/S announced that it has entered into a drug discovery collaboration with Merck & Co. Inc. Nuevolution will apply its proprietary Chemetics® drug discovery technology to identify novel small molecule leads against several drug targets of interest to Merck. T Nuevolution will screen ...

drug discovery collaborations milestone payments synthesis

Nuevolution Announces Drug Discovery Alliance with Lexicon Pharmaceuticals

12-Jun-2008 - Nuevolution A/S announced a strategic alliance with Lexicon Pharmaceuticals, Inc. aimed at the discovery of novel small molecule lead compounds for highly validated drug targets. Under the terms of the alliance, Nuevolution's proprietary Chemetics® drug discovery technology will be applied to ...

genes milestone payments

Nuevolution A/S announces a new CEO

08-Sep-2005 - Nuevolution A/S announced that Knud Aunstrup is stepping down as the company's CEO and that he will be replaced in the position by Alex Haahr Gouliaev. The new management team of Nuevolution now comprises Alex Haahr Gouliaev (CEO), Henrik Pedersen (CSO) and Mark Payne (CFO).Knud Aunstrup will ...

chemistry

Nuevolution A/S and Biovitrum AB in drug discovery collaboration

14-Jun-2005 - Nuevolution A/S, Denmark and Biovitrum AB, Sweden have signed a drug discovery collaboration focused on the indication area of metabolic diseases. Under the terms of the agreement, Nuevolution will use its proprietary Chemetics® drug discovery technology to find new drug leads against a disease ...

Denmark drug discovery collaborations ligands +2

Nuevolution Generates World's Largest Drug Library And Identifies Novel High Potency Cancer Leads

19-Apr-2004 - Copenhagen. Nuevolution A/S, a privately held drug discovery company announced that it has generated what it believes to be the world's largest drug-like library comprising 100 million diverse compounds synthesised in a single test tube. The Company also identified novel drug lead candidates that ...

biotechnology chemistry Denmark +6